Uncategorized

Serum Institute Seeks Emergency Use Authorisation For Its rBCG Tuberculosis Vaccine

(link to source)

The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII).

Related posts

North Korea's Suspected Covid-19 Caseload Nears 2 Million

admin

One More Held For Lynching Jharkhand Man

admin

Government To Meet Cab Aggregators Tomorrow Amid Rise In Consumer Complaints

admin

Leave a Comment